Scarica l'app Stockscreener
1.58
1.28%
0.02
Precedente Chiudi:
$1.56
Aprire:
$1.56
Volume 24 ore:
34,009
Relative Volume:
0.28
Capitalizzazione di mercato:
$8.87M
Reddito:
$125.00K
Utile/perdita netta:
$-14.64M
Rapporto P/E:
-0.3058
EPS:
-5.1674
Flusso di cassa netto:
$-15.06M
1 W Prestazione:
-1.25%
1M Prestazione:
-5.39%
6M Prestazione:
-54.34%
1 anno Prestazione:
-72.38%
Intervallo 1D:
$1.54
$1.58
Intervallo di 1 settimana:
$1.5066
$1.64
Portata 52W:
$1.47
$6.025
Imunon Inc Stock (IMNN) Company Profile
Nome
Imunon Inc
Settore
Industria
Telefono
(609) 896-9100
Indirizzo
997 LENOX DRIVE, LAWRENCEVILLE
Compare IMNN vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IMNN
Imunon Inc
|
1.58 | 8.87M | 125.00K | -14.64M | -15.06M | -5.1674 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Imunon Inc Borsa (IMNN) Ultime notizie
Imunon (IMNN) Q2 2026 Filing Snapshot: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Stock Move: Shares Move 1.25% Lower on the DayEarnings Revision Upgrade - vinanet.vn
Imunon (IMNN) General Counsel and Corp Sec Susan Eylward Sells 2,449 Shares - GuruFocus
Imunon (IMNN) pays executive chair with 7,147 shares - Stock Titan
Imunon (IMNN) CEO takes 6,615 shares instead of cash pay - Stock Titan
Imunon (IMNN) pays CMO with 3,516-share stock grant - Stock Titan
Imunon (IMNN) counsel gets stock in lieu of pay, then sells 2,449 shares - Stock Titan
Imunon General Counsel Susan Eylward disposes of 2,449 common shares worth $3,992.54 - Bitget
Imunon (IMNN) Q2 2026 Earnings: Narrower-Than-Expected Loss Drives 4.43% BounceProduct Revenue Analysis - vinanet.vn
Imunon Inc. (IMNN) Advances 4.43% as Biotech Stock Tests Key Resistance at $1.73Fair Value Gap - dars.gov.et
Imunon Inc (NASDAQ: IMNN) Share Price, IMNN Stock News, IMNN Share Price & Updates - Kalkine
Armistice Capital (IMNN) discloses 9.99% Imunon stake via Master Fund - Stock Titan
IMUNON to Hold First Quarter 2025 Financial Results and Business Update Conference Call on Monday, May 12, 2025 - kalkine.ca
Earnings call transcript: Imunon beats Q2 2026 EPS forecast as shares stay weak - Investing.com UK
Imunon (IMNN) Q2 2026 Earnings Call Transcript - The Globe and Mail
Imunon Q2 2026 Loss Shrinks 42.6%: -$0.54/Share vs -$0.94 Expected - AlphaStreet
Imunon Q2 2026 Earnings Call Transcript - MarketBeat
Imunon Adopts New Equity-Based Executive Compensation Program - TipRanks
Imunon, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Imunon, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Form 8K Imunon Inc For: 11 August By Investing.com - Investing.com Australia
Q2 2026 Imunon Inc Earnings Call Transcript - GuruFocus
Imunon Inc (IMNN) Advances Phase 3 Trial Amidst Challenging Valu - GuruFocus
Imunon, Inc. 2Q 2026: Net loss $(2.83M), EPS $(0.54) — 10-Q Summary - TradingView
IMUNON Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila Times
Imunon Q2 net loss widens slightly as R&D costs rise - tradingview.com
IMUNON reports $2.8 million Q2 loss as OVATION 3 enrollment advances - Quiver Quantitative
Imunon reports Q2 2026 net loss $2.8M; cash $6.9M, advances Phase 3 OVATION 3 - TradingView
BRIEF-Imunon Q2 EPS USD -0.54 - TradingView
IMNN Q2 2026 Earnings: EPS Loss of $0.54 Beats Estimates by 42.83%; Stock Rises 0.61Quarterly Earnings Report - vinanet.vn
IMNN Q1 2026 Earnings: Narrower Loss Beats Estimates as Clinical Pipeline AdvancesEarnings Cycle Outlook - vinanet.vn
Imunon Inc expected to post a loss of 93 cents a shareEarnings Preview - TradingView
Imunon Inc. (CBO0.SG) cash flow - Yahoo Finance UK
Imunon (IMNN.US) will release its earnings report on August 11. - Moomoo
Imunon (IMNN) General Counsel Susan Eylward Sells 2,541 Shares - GuruFocus
Imunon, Inc. (IMNN) director granted 6,934 shares in lieu of fees - stocktitan.net
Imunon (IMNN) director granted 6,934 shares of stock for board fees - Stock Titan
Imunon (IMNN) grants director 6,934 shares instead of cash board fees - Stock Titan
Imunon (NASDAQ: IMNN) awards director 6,180 shares for board fees - Stock Titan
Imunon, Inc. (IMNN) general counsel grants and sells 2,541 shares - stocktitan.net
Imunon, Inc. (IMNN) grants chair 6,358 shares instead of cash salary - Stock Titan
Imunon, Inc. (IMNN) CMO granted stock in lieu of cash pay - Stock Titan
Imunon, Inc. (IMNN) CEO awarded 5,010-share stock grant as compensation - Stock Titan
IMUNON to Hold Second Quarter 2026 Financial Results and Business Update Conference Call on Tuesday, August 11, 2026 - The Manila Times
Imunon Inc. (IMNN) Q1 2026 Earnings: Narrower Net Loss Beats Expectations, Shares Edge HigherEarnings Deceleration Risk - vinanet.vn
Imunon (IMNN.US) will release its earnings report on August 4. - Moomoo
IMUNON reports faster-than-expected enrollment in ovarian cancer trial By Investing.com - Investing.com Nigeria
IMUNON Reports Faster-Than-Expected Enrollment in Phase 3 OVATION 3 Trial of IMNN-001 for Advanced Ovarian Cancer - Quiver Quantitative
IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer - GlobeNewswire
Imunon Q1 2026 Earnings: EPS Surprises to the Upside as Narrower Loss Beats EstimatesEarnings Per Share - vinanet.vn
IMNN|Imunon Inc|Price:1.514|Chg%:+0.004 - TradingKey
Imunon Inc (IMNN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Imunon Inc Azioni (IMNN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Imunon Inc Azioni (IMNN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Eylward Susan | General Counsel and Corp Sec |
Aug 17 '26 |
Sale |
1.63 |
2,449 |
3,993 |
2,896 |
| Eylward Susan | General Counsel and Corp Sec |
Aug 03 '26 |
Sale |
1.57 |
2,541 |
3,977 |
2,896 |
| Eylward Susan | General Counsel and Corp Sec |
Jul 20 '26 |
Sale |
1.78 |
2,150 |
3,830 |
2,896 |
| Eylward Susan | General Counsel and Corp Sec |
Jul 06 '26 |
Sale |
1.88 |
920 |
1,730 |
2,896 |
| Eylward Susan | General Counsel and Corp Sec |
Jun 29 '26 |
Sale |
1.75 |
11,800 |
20,674 |
2,896 |
0.86%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):